Monthly Archives: November 2016

Last week, I attended World Orphan Drug Congress in Belgium. It was my first WODC, and it was a productive three days in Brussels – even if it was held at the airport hotel, and we never left the building! The congress agenda covered a wide range of topics in the rare and orphan diseaseRead more

DURHAM, N.C., November 16, 2016 — From discovery to approval to market entry, patient advocacy groups are quickly expanding their role in drug development as they target vast unmet needs in cancer and rare disease treatment. One of Premier Research’s rare disease strategists will discuss this trend, and its implications for the industry, at thisRead more

As it was starting to get cold in the Northeast, a group of us snowbirded down to warm Florida for the CNS Summit. Before the conference began, we participated in STARR Coalition’s annual meeting. STARR Coalition is a remarkable group whose mission is to create meaningful change by increasing communication, partnerships, and goodwill among stakeholdersRead more

DURHAM, N.C., November 10, 2016 — Researchers developing treatments for neurodegenerative disorders face some of the biggest hurdles in planning and conducting clinical drug trials. Get advice on navigating this difficult terrain by attending a Premier Research webinar on Tuesday, November 15. Neurodegenerative Disease Research: Steps to a Successful Clinical Trial will describe a complexRead more

DURHAM, N.C., October 9, 2016 — Premier Research’s quality assurance chief will chair a session at the Research Quality Association’s 2016 Annual Conference in Brighton, U.K. Nicky Dodsworth, Vice President of Global Quality Assurance, will lead the session taking place Thursday, November 10, starting at 9 a.m. Stream C, Session 1 at the RQA conferenceRead more

No more posts
Phone Us Now
Email Us Now